Generics Labeling 2014 Conference

Topics

• Comply with the Drug Quality and Security Act HR 3204 (DQSA) while managing counterfeiting risk by developping track and trace systems
• Minimize documentation errors that carry the potential for adverse events by a repeatable label review process in the front end
• Repeatable protocols for the timely notification of new generics-based safety signals to branded drug companies
• Ensure FDA compliance by convert Structured Product Labeling (SPL) data into the Physician Labeling Rule (PLR) format
• The impact a global labeling harmonization strategy holds for patient safety and global compliance optimization